Developer docs
API playgroundTry for free, no card

Search company profiles

Aurora Nordic

Full company profile

uuid00311up

Namestring
Aurora Nordic
Legal namestring
Aurora Cannabis Inc.
Websiteurl
auroranordic.dk
Company typeenum
Public
Founded yearint
2014
Descriptiontext

Aurora Nordic is the Danish regional subsidiary of Aurora Cannabis Inc. (NASDAQ: ACB), a Canadian-headquartered pharmaceutical-grade medical cannabis producer operating across Europe. The entity is registered in Odense, Denmark and operates as part of the broader "Aurora Europe" division, which runs wholly-owned regional subsidiaries in Germany, Poland, the UK, and Denmark. Aurora Nordic and its sister entities manufacture and distribute medical cannabis products through EU-GMP and GACP compliant production facilities located in Germany, dispensing products to patients via prescription-based access through licensed pharmacies across multiple European jurisdictions.

The company's core technology revolves around pharmaceutical-grade cannabis cultivation and production, including advanced plant genetics, proprietary cultivar development, and breeding techniques developed since 2014. The product portfolio consists of five brands — Aurora Medical (the flagship), Pedanios, IndiMed, Daily Special, and SANRAF — each positioned to address specific patient segments across Europe. Quality assurance processes include consistent testing for purity, potency, and active ingredient content to meet pharmaceutical-grade safety and dosing standards. The business operates a B2B2C model: it engages healthcare professionals (physicians and prescribers) through enterprise field sales and education initiatives, who in turn prescribe Aurora's products to patients, with products ultimately dispensed through licensed pharmacy networks in each regulated market.

Short descriptiontext

Aurora Nordic is the Danish regional arm of Aurora Cannabis Inc., producing and distributing pharmaceutical-grade medical cannabis through EU-GMP facilities across Europe. It serves patients and healthcare professionals via a multi-brand portfolio (Aurora Medical, Pedanios, IndiMed, Daily Special, SANRAF) dispensed through licensed pharmacies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersOdense, Denmark
HQ citystring
Odense
HQ countrystring
Denmark
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical cannabis production, pharmaceutical cannabis manufacturing, EU-GMP cannabis, cannabis genetics breeding, medical cannabis brands
Industry1 code
PRIMARYCRANAFAB
Medical Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
NAICS code2 codes
  • Medicinal and Botanical Manufacturing325411
  • Pharmaceutical Preparation Manufacturing325412
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Medical Cannabis Manufacturing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Cannabis Product Sales
TypeTransaction Fee
Description

Sale of pharmaceutical-grade medical cannabis products including flower, oils, and other formulations to patients across Europe through prescription-based access

auroramedicine.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1Aurora Medical
Description

Medical cannabis brand offering pharmaceutical-grade products

auroramedicine.com
+4 more records
Core offering1 text field

Aurora Nordic manufactures and distributes pharmaceutical-grade medical cannabis products (flower, oils, and formulations) in EU-GMP compliant facilities for distribution across European markets. The company operates a multi-brand portfolio (Aurora Medical, Pedanios, IndiMed, Daily Special, SANRAF) and sells these products through licensed pharmacies via prescription-based access, supported by direct engagement with prescribing healthcare professionals.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Aurora Nordic operates as part of Aurora's European operations, offering a multi-brand portfolio of pharmaceutical-grade medical cannabis products. The portfolio includes Aurora Medical (the primary brand), Pedanios, IndiMed, Daily Special, and SANRAF. The company produces cannabis-based treatments in EU-GMP compliant facilities and offers these brands across multiple European countries to meet patient needs.

Product and service5 records
1Aurora Medical
CategoryMedical Cannabis Brand
Description

Aurora's primary medical cannabis brand offering pharmaceutical-grade cannabis-based treatments, including flower, oils, and other formulations, dispensed via prescription through licensed pharmacies across European markets.

2Pedanios
CategoryMedical Cannabis Brand
Description

Medical cannabis brand under Aurora's portfolio serving European patients, offering pharmaceutical-grade cannabis-based treatments dispensed via prescription through licensed pharmacies.

3IndiMed
CategoryMedical Cannabis Brand
Description

Medical cannabis brand offering treatment options for patients in Europe, providing pharmaceutical-grade cannabis-based products through prescription-based access.

4Daily Special
CategoryMedical Cannabis Brand
Description

Medical cannabis brand within Aurora's European product portfolio, offering pharmaceutical-grade cannabis-based treatments to patients through licensed pharmacies.

5SANRAF
CategoryMedical Cannabis Brand
Description

Medical cannabis brand offered by Aurora in the European market, providing pharmaceutical-grade cannabis-based treatments through prescription-based dispensing channels.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to advance physician education and experience with medical cannabis, providing resources and platforms for healthcare professionals

Strategic tierCoreTypeStrategic or Co-development Partner
Description

German Cannabis Interest Group partnership to help shape the future of medical cannabis in Germany through industry collaboration

3BPC (Bundescannabisplan)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership with leading associations to shape policy and future of medical cannabis in Europe

auroramedicine.com
Peers10 records
TypeDirect peer
Description

German medical cannabis distributor and EU-GMP importer supplying pharmacies across Germany. Directly comparable in go-to-market model (pharmacy channel, prescriber engagement) and target product types.

TypeBroad incumbent
Description

Canadian parent of several European medical cannabis operations (including Spectrum Therapeutics), a broad incumbent with overlapping product categories and EU-GMP positioning. Comparable in target customers and prescription-led model.

TypeDirect peer
Description

German EU-GMP-certified medical cannabis producer supplying German pharmacies. Direct competitor in Aurora Nordic's largest European market with comparable pharmaceutical-grade positioning.

TypeRegional player
Description

Australian medical cannabis producer expanding into European markets via distribution agreements. Comparable as an EU-GMP-aligned medical cannabis peer targeting European pharmacy channels, though primarily serving different geographies.

TypeBroad incumbent
Description

Canadian cannabis producer with European medical cannabis ambitions through strategic partnerships and EU-GMP-aligned operations. Broad incumbent in the same pharmaceutical-grade medical cannabis category.

TypeDirect peer
Description

Danish-based medical cannabis producer listed on Nasdaq First North, supplying the Nordic market with prescription-based cannabis oil products. Closest direct competitor given shared Danish base, similar regulatory positioning, and overlapping prescriber channels.

TypeBroad incumbent
Description

Parent company of Aurora Nordic; publicly traded on NASDAQ (ACB) and produces medical cannabis under the same EU-GMP framework, operating across Europe, Canada and globally. Directly comparable in product category, regulatory posture and customer base.

TypeDirect peer
Description

Dutch producer of standardized medicinal cannabis flower under EU-GMP, supplying Germany and other European countries. Compares on pharmaceutical-grade standardization, regulatory compliance and pharmacy-led distribution model.

TypeOthers
Description

European-focused medical cannabis education and matching platform serving patients and physicians. Adjacent ecosystem participant that complements pharmacy-based distribution models like Aurora Nordic's, supporting physician and patient education.

10Tilray Brands
TypeBroad incumbent
Description

Global cannabis company with significant European medical cannabis footprint in Germany, Portugal and other markets. Broad incumbent with overlapping EU-GMP operations and competing brands targeting the same prescribers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries9 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aurora Nordic

Pharmaceutical Medical Cannabis Manufacturingauroranordic.dk

Aurora Nordic is the Danish regional arm of Aurora Cannabis Inc., producing and distributing pharmaceutical-grade medical cannabis through EU-GMP facilities across Europe. It serves patients and healthcare professionals via a multi-brand portfolio (Aurora Medical, Pedanios, IndiMed, Daily Special, SANRAF) dispensed through licensed pharmacies.

What Aurora Nordic does

Aurora Nordic is the Danish regional subsidiary of Aurora Cannabis Inc. (NASDAQ: ACB), a Canadian-headquartered pharmaceutical-grade medical cannabis producer operating across Europe. The entity is registered in Odense, Denmark and operates as part of the broader "Aurora Europe" division, which runs wholly-owned regional subsidiaries in Germany, Poland, the UK, and Denmark. Aurora Nordic and its sister entities manufacture and distribute medical cannabis products through EU-GMP and GACP compliant production facilities located in Germany, dispensing products to patients via prescription-based access through licensed pharmacies across multiple European jurisdictions.

The company's core technology revolves around pharmaceutical-grade cannabis cultivation and production, including advanced plant genetics, proprietary cultivar development, and breeding techniques developed since 2014. The product portfolio consists of five brands — Aurora Medical (the flagship), Pedanios, IndiMed, Daily Special, and SANRAF — each positioned to address specific patient segments across Europe. Quality assurance processes include consistent testing for purity, potency, and active ingredient content to meet pharmaceutical-grade safety and dosing standards. The business operates a B2B2C model: it engages healthcare professionals (physicians and prescribers) through enterprise field sales and education initiatives, who in turn prescribe Aurora's products to patients, with products ultimately dispensed through licensed pharmacy networks in each regulated market.

Aurora Nordic firmographics

Firmographics
Name
Aurora Nordic
Legal name
Aurora Cannabis Inc.
Website
https://auroranordic.dk
Company type
Public
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
Aurora Nordic is the Danish regional arm of Aurora Cannabis Inc., producing and distributing pharmaceutical-grade medical cannabis through EU-GMP facilities across Europe. It serves patients and healthcare professionals via a multi-brand portfolio (Aurora Medical, Pedanios, IndiMed, Daily Special, SANRAF) dispensed through licensed pharmacies.
Ownership category
akta.pro rank

Aurora Nordic industry classification

Industry
Product category
Pharmaceutical Medical Cannabis Manufacturing
NAICS
Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412)
SIC
Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYCRANAFAB
Medical Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)

Keywords

  • Medical cannabis production
  • Pharmaceutical cannabis manufacturing
  • EU-GMP cannabis
  • Cannabis genetics breeding
  • Medical cannabis brands

Where Aurora Nordic is headquartered

Location

Headquarters

HQ city
Odense
HQ country
Denmark
HQ region
Europe

Offices2 records

Markets served

Aurora Nordic business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Medical Cannabis Product Sales: Sale of pharmaceutical-grade medical cannabis products including flower, oils, and other formulations to patients across Europe through prescription-based access

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Aurora Nordic product offering

Product offering

Core offering

Aurora Nordic manufactures and distributes pharmaceutical-grade medical cannabis products (flower, oils, and formulations) in EU-GMP compliant facilities for distribution across European markets. The company operates a multi-brand portfolio (Aurora Medical, Pedanios, IndiMed, Daily Special, SANRAF) and sells these products through licensed pharmacies via prescription-based access, supported by direct engagement with prescribing healthcare professionals.

Product overview

Aurora Nordic operates as part of Aurora's European operations, offering a multi-brand portfolio of pharmaceutical-grade medical cannabis products. The portfolio includes Aurora Medical (the primary brand), Pedanios, IndiMed, Daily Special, and SANRAF. The company produces cannabis-based treatments in EU-GMP compliant facilities and offers these brands across multiple European countries to meet patient needs.

Differentiator

Problem solved

Functional benefit

Brands

  • Aurora Medical: Medical cannabis brand offering pharmaceutical-grade products
  • Pedanios
  • IndiMed
  • Daily Special
  • SANRAF

Products and services

  • Aurora Medical Aurora's primary medical cannabis brand offering pharmaceutical-grade cannabis-based treatments, including flower, oils, and other formulations, dispensed via prescription through licensed pharmacies across European markets.
  • Pedanios Medical cannabis brand under Aurora's portfolio serving European patients, offering pharmaceutical-grade cannabis-based treatments dispensed via prescription through licensed pharmacies.
  • IndiMed Medical cannabis brand offering treatment options for patients in Europe, providing pharmaceutical-grade cannabis-based products through prescription-based access.
  • Daily Special Medical cannabis brand within Aurora's European product portfolio, offering pharmaceutical-grade cannabis-based treatments to patients through licensed pharmacies.
  • SANRAF Medical cannabis brand offered by Aurora in the European market, providing pharmaceutical-grade cannabis-based treatments through prescription-based dispensing channels.

Companies that use Aurora Nordic

Customer profile

Segments2 records

Ideal customer profiles2 records

Aurora Nordic technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Aurora Nordic partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Copeia - Physicians Experience PlatformcoreStrategic or Co-development PartnerPartnership to advance physician education and experience with medical cannabis, providing resources and platforms for healthcare professionals
  • IG Hanf (Interessengemeinschaft Hanf)coreStrategic or Co-development PartnerGerman Cannabis Interest Group partnership to help shape the future of medical cannabis in Germany through industry collaboration
  • BPC (Bundescannabisplan)minorStrategic or Co-development PartnerPartnership with leading associations to shape policy and future of medical cannabis in Europe

Scale indicators3 records

Aurora Nordic competitors and assessment

Company assessment

Direct peers

  • Cannamedical: German medical cannabis distributor and EU-GMP importer supplying pharmacies across Germany. Directly comparable in go-to-market model (pharmacy channel, prescriber engagement) and target product types.
  • Demecan: German EU-GMP-certified medical cannabis producer supplying German pharmacies. Direct competitor in Aurora Nordic's largest European market with comparable pharmaceutical-grade positioning.
  • STENOCARE: Danish-based medical cannabis producer listed on Nasdaq First North, supplying the Nordic market with prescription-based cannabis oil products. Closest direct competitor given shared Danish base, similar regulatory positioning, and overlapping prescriber channels.
  • Bedrocan: Dutch producer of standardized medicinal cannabis flower under EU-GMP, supplying Germany and other European countries. Compares on pharmaceutical-grade standardization, regulatory compliance and pharmacy-led distribution model.

Broad incumbents

  • Canopy Growth Corporation: Canadian parent of several European medical cannabis operations (including Spectrum Therapeutics), a broad incumbent with overlapping product categories and EU-GMP positioning. Comparable in target customers and prescription-led model.
  • OrganiGram Holdings: Canadian cannabis producer with European medical cannabis ambitions through strategic partnerships and EU-GMP-aligned operations. Broad incumbent in the same pharmaceutical-grade medical cannabis category.
  • Aurora Cannabis Inc. Parent company of Aurora Nordic; publicly traded on NASDAQ (ACB) and produces medical cannabis under the same EU-GMP framework, operating across Europe, Canada and globally. Directly comparable in product category, regulatory posture and customer base.
  • Tilray Brands: Global cannabis company with significant European medical cannabis footprint in Germany, Portugal and other markets. Broad incumbent with overlapping EU-GMP operations and competing brands targeting the same prescribers.

Regional players

  • Little Green Pharma: Australian medical cannabis producer expanding into European markets via distribution agreements. Comparable as an EU-GMP-aligned medical cannabis peer targeting European pharmacy channels, though primarily serving different geographies.

Others

  • Cannify: European-focused medical cannabis education and matching platform serving patients and physicians. Adjacent ecosystem participant that complements pharmacy-based distribution models like Aurora Nordic's, supporting physician and patient education.

Market position

Strengths5 records

Weaknesses5 records

Key risks5 records

Key highlights6 records

Customer concentration

Aurora Nordic social profiles

Digital presence

Aurora Nordic compliance and trust

Trust signal

Compliance2 records

Aurora Nordic financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aurora Nordic leadership team

Management profile

Number of profiles

Aurora Nordic subsidiaries and ownership

Company hierarchy

Subsidiaries9 records

Aurora Nordic funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aurora Nordic M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aurora Nordic

What does Aurora Nordic do?

Aurora Nordic manufactures and distributes pharmaceutical-grade medical cannabis products (flower, oils, and formulations) in EU-GMP compliant facilities for distribution across European markets. The company operates a multi-brand portfolio (Aurora Medical, Pedanios, IndiMed, Daily Special, SANRAF) and sells these products through licensed pharmacies via prescription-based access, supported by direct engagement with prescribing healthcare professionals.

Is Aurora Nordic a public or private company?

Aurora Nordic is a public company. It is classified as corporate owned and is currently operating.

When was Aurora Nordic founded?

Aurora Nordic was founded in 2014. It employs 11 to 50 people.

Where is Aurora Nordic based?

Aurora Nordic is headquartered in Odense, Denmark, in the Europe region.

How does Aurora Nordic make money?

One revenue line is on record: medical Cannabis Product Sales.

Who are Aurora Nordic's main competitors?

Direct peers on record are Cannamedical, Demecan, STENOCARE and Bedrocan. Broad incumbents are Canopy Growth Corporation, OrganiGram Holdings, Aurora Cannabis Inc. and Tilray Brands. Little Green Pharma is listed as a regional player. Cannify is listed as an others.

Does Aurora Nordic have an API?

No public API is recorded for Aurora Nordic.

What industry is Aurora Nordic in?

Aurora Nordic's product category is Pharmaceutical Medical Cannabis Manufacturing. Its primary akta.pro industry code is CRANAFAB, Medical Cannabis Dispensaries. Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals